In women 50 to 69 years of age, screen detection was statistically significantly associated with smaller primary tumor size, less frequent lymph node metastasis, special histological type, lower grade of differentiation and positive hormone receptor status (ER and PR) compared with non-screen-detected cancers. This evidence concerns the gene ESR1 and cancer.